// App-Quantinova.ai

1733 : Improvement in Weight and Total Cholesterol and Their Association with Survival in Ruxolitinib-Treated Patients with Myelofibrosis From COMFORT-I

Researchers

Presenter

  • Srdan Verstovsek

Principal Investigators

  • Vikas Gupta

  • John Mascarenhas

  • Ehab Atallah

  • William Sun

  • Victor A. Sandor

  • Jason Gotlib

Medical Centers

  • Biostatistics, Princess Margaret Hospital, University of Toronto, Toronto, ON, Canada

  • Mayo Clinic, Scottsdale, AZ

Locations

  • United States

  • Canada

Companies

  • Incyte Corporation

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Myelofibrosis

Biomarkers

  • Cholesterol

  • Body mass index

Drug/Treatment

  • Ruxolitinib phosphate

Outcome

  • N/A

Study Design

  • randomized

  • pharmacodynamics

  • cross over

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved